Alex Lobo
Investor Relations
Replay available
Inhibikase Therapeutics, Inc. (IKT) Q2 2023 Earnings Call
Inhibikase Therapeutics, Inc. (NASDAQ: IKT) Q2 2023 earnings conference call, held 2023-08-15. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Ed White
Analyst, HC Wainwright & Co.
Joe Fratelloli
Chief Financial Officer
Dr. Milton Werner
Chief Executive Officer
Unidentified Participant
Analyst
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Inhibikase Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:05.453 Good morning. Welcome to the Inhibit Case Therapeutic Second Quarter 2023 00:00:05.453 -- 00:00:10.818 Financial Results Conference Call. All participants will be in listen only mode. 00:00:10.818 -- 00:00:15.781 Should you need assistance, please signal a conference specialist by pressing star then 00:00:15.781 -- 00:00:21.386 zero on your telephone keypad. After today's presentation, there will be an opportunity 00:00:21.386 -- 00:00:26.830 to ask questions. To ask a question, you may press star then one on your telephone 00:00:26.830 -- 00:00:31.815 keypad. To withdraw your question, please press star then two. 00:00:31.815 -- 00:00:36.397 Please note this event is being recorded. I would now like to turn the conference over 00:00:36.397 -- 00:00:42.458 to Alex Lobo, Stern Investor Relations. Please go ahead. 00:00:43.519 -- 00:00:47.841 Good morning and welcome to the Navigate Therapeutics second quarter of 2023 financial 00:00:47.841 -- 00:00:50.702 results conference call and audio webcast. 00:00:50.702 -- 00:00:55.464 With me today is Dr. Milton Werner, chief executive officer, 00:00:55.464 -- 00:00:57.958 chief financial officer. 00:00:57.958 -- 00:01:00.319 On Monday, August 14, 2023, 00:01:00.319 -- 00:01:04.902 Inhibit Case issued a press release announcing financial results for the second quarter 00:01:04.902 -- 00:01:07.192 ended June 30, 2023. 00:01:08.124 -- 00:01:12.427 We encourage everyone to read yesterday's press release, as well as Inhibit Case's quarterly 00:01:12.427 -- 00:01:17.749 report on Form 10-Q, which has been filed with the SEC. 00:01:17.890 -- 00:01:23.053 The company's press release and quarterly report are also available on Inhibit Case's 00:01:23.053 -- 00:01:25.913 website at inhibitcase.com. 00...